ArticlePloS one2026

Safety population size and duration of exposure prior to approval of new medicines: A database analysis of medicines centralised approved in the European Union between 2011 and 2023.

Luísa Bouwman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.